Funding Daily Summary
Funding Daily Summary: What Happened on November 18, 2026
Isomorphic Labs raises $5 billion in record biotech venture round
The AI drug-design company plans to move its preclinical pipeline toward clinical testing. Seawolf Therapeutics also launched with $100 million and a Sanofi deal.
Today in brief
Isomorphic Labs secured a $5 billion Series C, the largest biotech venture round on record, according to BioCentury’s database.12 It plans to use the funding to expand its AI drug-design platform and move its pipeline toward clinical testing.12
Seawolf Therapeutics launched with $100 million in Series A funding and a Sanofi deal worth up to $1.2 billion in potential milestone payments.3
Isomorphic raises $5 billion as its programs remain preclinical
Greenoaks Capital and Sequoia Capital co-led Isomorphic Labs’ $5 billion Series C, with Andreessen Horowitz and existing investors also participating.124 Alphabet continued to invest.24
The round breaks the previous record of $3 billion, raised by Altos Labs.13
Isomorphic said it will use the proceeds to expand its AI drug-design engine, biological models, and infrastructure for translational and clinical development.24 The company reports positive preclinical results in oncology and immunology, but its internal programs have not entered clinical testing.34
The Series C came six months after Isomorphic raised $2.1 billion in a Series B.14 Across three rounds since March 2025, the company has disclosed $7.7 billion in fundraising.14
Before the financing, Bloomberg reported that Isomorphic was seeking a valuation of about $50 billion.15
Seawolf launches with $100 million and a Sanofi deal
Seawolf Therapeutics emerged from stealth with a $100 million Series A and a multi-target agreement with Sanofi.3 The deal could provide up to $1.2 billion in milestone payments.3
Also worth knowing
-
W
Orakl Oncology raised $34 million in a Series A to expand into lung and gastric cancer. It says its model predicts trial outcomes with 90% accuracy in a preprint that has not been peer reviewed.3
-
M
Flagship Pioneering committed £100 million to establish its first company-creation lab outside the United States, in London.6
-
M
INFevo raised more than CNY 100 million in a Pre-A round to expand its virtual-cell models and automated laboratory platform.6
Also published
- Isomorphic Labs raises $5bn in massive third round pharmaphorum
- AI drugmaker Isomorphic restocks with $5B fundraise BioPharma Dive